Results 261 to 270 of about 18,058,309 (312)

Harnessing <i>Toxoplasma gondii</i> microneme proteins for serodiagnosis and vaccine development: a review. [PDF]

open access: yesAnn Med
Ji Y   +9 more
europepmc   +1 more source

Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine development. [PDF]

open access: yesCell Rep
Bader DLV   +40 more
europepmc   +1 more source

Developments in Vaccine Adjuvants

2021
Vaccines, including subunit, recombinant, and conjugate vaccines, require the use of an immunostimulator/adjuvant for maximum efficacy. Adjuvants not only enhance the strength and longevity of immune responses but may also influence the type of response. In this chapter, we review the adjuvants that are available for use in human vaccines, such as alum,
Firdaus, Farrhana Ziana   +2 more
openaire   +4 more sources

Carbohydrates in Vaccine Development

Current Drug Delivery, 2019
Despite advances in the development of new vaccines, there are still some diseases with no vaccine solutions. Therefore, further efforts are required to more comprehensively discern the different antigenic components of these microorganisms on a molecular level.
Aljohani, Salwa   +3 more
openaire   +4 more sources

Vaccine Development

Pediatric Clinics of North America
This article considers ethical considerations surrounding pediatric vaccine development for pandemic preparedness, examines some historical cases of pediatric vaccines developed during past smallpox, influenza, and 2019 coronavirus disease pandemics, and discusses the current state of vaccine development for pandemic preparedness, including vaccines ...
Elizabeth A D, Hammershaimb   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy